FDG PET in oral and oropharyngeal cancer. Value for confirmation of N0 neck and detection of occult metastases

Oral Oncology

Volumn 44, Issue 1, 2008, Pages 31-36

  Krabbe, Christiaan A ^a   Dijkstra, Pieter U ^a   Pruim, Jan ^a   van der Laan, Bernard F M ^a   van der Wal, Jacqueline E ^a   Gravendeel, Joost P ^a   Roodenburg, Jan L N ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Lymph node metastases; N0 neck; Oral and oropharyngeal cancer; Positron emission tomography; Squamous cell carcinoma

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MALE; METASTASIS; MOUTH CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; OROPHARYNX CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 37049029982     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.12.003     Document Type: Article

References (31)

1. Snow G.B., Annyas A.A., van Slooten E.A., Bartelink H., and Hart A.A. Prognostic factors of neck node metastasis. Clin Otolaryngol Allied Sci 7 3 (1982) 185-192
2. Leemans C.R., Tiwari R., Nauta J.J., van der Waal I., and Snow G.B. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 71 2 (1993) 452-456
3. van den Brekel M.W., van der Waal I., Meijer C.J., Freeman J.L., Castelijns J.A., and Snow G.B. The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. Laryngoscope 106 8 (1996) 987-991
4. Shah J.P., Candela F.C., and Poddar A.K. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer 66 1 (1990) 109-113
5. Teichgraeber J.F., and Clairmont A.A. The incidence of occult metastases for cancer of the oral tongue and floor of the mouth: treatment rationale. Head Neck Surg 7 1 (1984) 15-21
6. Castelijns J.A., and van den Brekel M.W. Imaging of lymphadenopathy in the neck. Eur Radiol 12 4 (2002) 727-738
7. van den Brekel M.W., Castelijns J.A., Stel H.V., Golding R.P., Meyer C.J., and Snow G.B. Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study. Eur Arch Otorhinolaryngol 250 1 (1993) 11-17
8. Righi P.D., Kopecky K.K., Caldemeyer K.S., Ball V.A., Weisberger E.C., and Radpour S. Comparison of ultrasound-fine needle aspiration and computed tomography in patients undergoing elective neck dissection. Head Neck 19 7 (1997) 604-610
9. Takes R.P., Righi P., Meeuwis C.A., Manni J.J., Knegt P., Marres H.A., et al. The value of ultrasound with ultrasound-guided fine-needle aspiration biopsy compared to computed tomography in the detection of regional metastases in the clinically negative neck. Int J Radiat Oncol Biol Phys 40 5 (1998) 1027-1032
10. Weiss M.H., Harrison L.B., and Isaacs R.S. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg 120 7 (1994) 699-702
11. Adams S., Baum R.P., Stuckensen T., Bitter K., and Hor G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 25 9 (1998) 1255-1260
12. van den Brekel M.W., Castelijns J.A., Reitsma L.C., Leemans C.R., van der Waal I., and Snow G.B. Outcome of observing the N0 neck using ultrasonographic-guided cytology for follow-up. Arch Otolaryngol Head Neck Surg 125 2 (1999) 153-156
13. Ng S.H., Yen T.C., Liao C.T., Chang J.T., Chan S.C., Ko S.F., et al. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med 46 7 (2005) 1136-1143
14. Myers L.L., and Wax M.K. Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer. J Otolaryngol 27 6 (1998) 342-347
15. Myers L.L., Wax M.K., Nabi H., Simpson G.T., and Lamonica D. Positron emission tomography in the evaluation of the N0 neck. Laryngoscope 108 2 (1998) 232-236
16. Brouwer J., de Bree R., Comans E.F., Castelijns J.A., Hoekstra O.S., and Leemans C.R. Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior?. Eur Arch Otorhinolaryngol 261 9 (2004) 479-483
17. Schoder H., Carlson D.L., Kraus D.H., Stambuk H.E., Gonen M., Erdi Y.E., et al. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med 47 5 (2006) 755-762
18. Civantos F.J., Gomez C., Duque C., Pedroso F., Goodwin W.J., Weed D.T., et al. Sentinel node biopsy in oral cavity cancer: correlation with PET scan and immunohistochemistry. Head Neck 25 1 (2003) 1-9
19. Hyde N.C., Prvulovich E., Newman L., Waddington W.A., Visvikis D., and Ell P. A new approach to pre-treatment assessment of the N0 neck in oral squamous cell carcinoma: the role of sentinel node biopsy and positron emission tomography. Oral Oncol 39 4 (2003) 350-360
20. Stoeckli S.J., Steinert H., Pfaltz M., and Schmid S. Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma. Head Neck 24 4 (2002) 345-349
21. Wensing B.M., Vogel W.V., Marres H.A., Merkx M.A., Postema E.J., Oyen W.J., et al. FDG-PET in the clinically negative neck in oral squamous cell carcinoma. Laryngoscope 116 5 (2006) 809-813
22. Hollenbeak C.S., Lowe V.J., and Stack Jr. B.C. The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neck. Cancer 92 9 (2001) 2341-2348
23. Pillsbury III H.C., and Clark M. A rationale for therapy of the N0 neck. Laryngoscope 107 10 (1997) 1294-1315
24. Barrera J.E., Miller M.E., Said S., Jafek B.W., Campana J.P., and Shroyer K.R. Detection of occult cervical micrometastases in patients with head and neck squamous cell cancer. Laryngoscope 113 5 (2003) 892-896
25. Stoeckli S.J., Pfaltz M., Steinert H., and Schmid S. Histopathological features of occult metastasis detected by sentinel lymph node biopsy in oral and oropharyngeal squamous cell carcinoma. Laryngoscope 112 1 (2002) 111-115
26. Woolgar J.A. Pathology of the N0 neck. Br J Oral Maxillofac Surg 37 3 (1999) 205-209
27. Boerner A.R., Weckesser M., Herzog H., Schmitz T., Audretsch W., Nitz U., et al. Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer. Eur J Nucl Med 26 3 (1999) 226-230
28. Hamberg L.M., Hunter G.J., Alpert N.M., Choi N.C., Babich J.W., and Fischman A.J. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification?. J Nucl Med 35 8 (1994) 1308-1312
29. Kubota K., Itoh M., Ozaki K., Ono S., Tashiro M., Yamaguchi K., et al. Advantage of delayed whole-body FDG-PET imaging for tumour detection. Eur J Nucl Med 28 6 (2001) 696-703
30. Brink I., Klenzner T., Krause T., Mix M., Ross U.H., Moser E., et al. Lymph node staging in extracranial head and neck cancer with FDG PET-appropriate uptake period and size-dependence of the results. Nuklearmedizin 41 2 (2002) 108-113
31. Laubenbacher C., Saumweber D., Wagner-Manslau C., Kau R.J., Herz M., Avril N., et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 36 10 (1995) 1747-1757